fenofibrate has been researched along with Diabetic Neuropathies in 8 studies
Pharmavit: a polyvitamin product, comprising vitamins A, D2, B1, B2, B6, C, E, nicotinamide, & calcium pantothene; may be a promising agent for application to human populations exposed to carcinogenic and genetic hazards of ionizing radiation; RN from CHEMLINE
Diabetic Neuropathies: Peripheral, autonomic, and cranial nerve disorders that are associated with DIABETES MELLITUS. These conditions usually result from diabetic microvascular injury involving small blood vessels that supply nerves (VASA NERVORUM). Relatively common conditions which may be associated with diabetic neuropathy include third nerve palsy (see OCULOMOTOR NERVE DISEASES); MONONEUROPATHY; mononeuropathy multiplex; diabetic amyotrophy; a painful POLYNEUROPATHY; autonomic neuropathy; and thoracoabdominal neuropathy. (From Adams et al., Principles of Neurology, 6th ed, p1325)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Fenofibrate was given to db/db mice in combination with anti-flt-1 hexamer and anti-flk-1 heptamer (VEGFR inhibition) for 12 weeks." | 1.40 | Therapeutic effects of fenofibrate on diabetic peripheral neuropathy by improving endothelial and neural survival in db/db mice. ( Chang, YS; Cho, YR; Hong, BY; Kim, HW; Kim, MY; Kim, TW; Kim, YS; Lim, JH; Park, CW, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (50.00) | 29.6817 |
| 2010's | 3 (37.50) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Teo, CHY | 3 |
| Lin, MT | 3 |
| Lee, IXY | 3 |
| Koh, SK | 3 |
| Zhou, L | 3 |
| Goh, DS | 3 |
| Choi, H | 3 |
| Koh, HWL | 3 |
| Lam, AYR | 3 |
| Lim, PS | 3 |
| Mehta, JS | 3 |
| Kovalik, JP | 3 |
| Coffman, TM | 3 |
| Tan, HC | 3 |
| Liu, YC | 3 |
| Kim, ES | 1 |
| Isoda, F | 1 |
| Kurland, I | 1 |
| Mobbs, CV | 1 |
| Cho, YR | 1 |
| Lim, JH | 1 |
| Kim, MY | 1 |
| Kim, TW | 1 |
| Hong, BY | 1 |
| Kim, YS | 1 |
| Chang, YS | 1 |
| Kim, HW | 1 |
| Park, CW | 1 |
| de Moraes, G | 1 |
| Layton, CJ | 1 |
| Ansquer, JC | 1 |
| Foucher, C | 1 |
| Aubonnet, P | 1 |
| Le Malicot, K | 1 |
| Zimmet, P | 1 |
| Yoshizawa, M | 1 |
| Takamura, T | 1 |
| Kobayashi, K | 1 |
| Davis, TM | 1 |
| Yeap, BB | 1 |
| Davis, WA | 1 |
| Bruce, DG | 1 |
3 reviews available for fenofibrate and Diabetic Neuropathies
| Article | Year |
|---|---|
Therapeutic targeting of diabetic retinal neuropathy as a strategy in preventing diabetic retinopathy.
Topics: Animals; Color Vision Defects; Contrast Sensitivity; Dark Adaptation; Diabetic Neuropathies; Diabeti | 2016 |
Fibrates and microvascular complications in diabetes--insight from the FIELD study.
Topics: Animals; Cardiovascular Diseases; Clofibric Acid; Diabetes Mellitus, Type 2; Diabetic Angiopathies; | 2009 |
[Soluble VCAM-1].
Topics: Biomarkers; Diabetes Mellitus; Diabetic Angiopathies; Diabetic Nephropathies; Diabetic Neuropathies; | 2002 |
5 other studies available for fenofibrate and Diabetic Neuropathies
| Article | Year |
|---|---|
Oral Peroxisome Proliferator-Activated Receptor-α Agonist Enhances Corneal Nerve Regeneration in Patients With Type 2 Diabetes.
Topics: Cornea; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Fenofibrate; Humans; Hypoglycemic Agents; | 2023 |
Oral Peroxisome Proliferator-Activated Receptor-α Agonist Enhances Corneal Nerve Regeneration in Patients With Type 2 Diabetes.
Topics: Cornea; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Fenofibrate; Humans; Hypoglycemic Agents; | 2023 |
Oral Peroxisome Proliferator-Activated Receptor-α Agonist Enhances Corneal Nerve Regeneration in Patients With Type 2 Diabetes.
Topics: Cornea; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Fenofibrate; Humans; Hypoglycemic Agents; | 2023 |
Oral Peroxisome Proliferator-Activated Receptor-α Agonist Enhances Corneal Nerve Regeneration in Patients With Type 2 Diabetes.
Topics: Cornea; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Fenofibrate; Humans; Hypoglycemic Agents; | 2023 |
Glucose-induced metabolic memory in Schwann cells: prevention by PPAR agonists.
Topics: Animals; Cell Line; Citric Acid Cycle; Diabetic Neuropathies; DNA Methylation; Energy Metabolism; Fe | 2013 |
Therapeutic effects of fenofibrate on diabetic peripheral neuropathy by improving endothelial and neural survival in db/db mice.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Adenosine Monophosphate; AMP-Activated Protein Kinases; Animals; Blood | 2014 |
Preventing diabetic complications: a primary care perspective.
Topics: Cost of Illness; Diabetes Complications; Diabetic Angiopathies; Diabetic Nephropathies; Diabetic Neu | 2009 |
Lipid-lowering therapy and peripheral sensory neuropathy in type 2 diabetes: the Fremantle Diabetes Study.
Topics: Aged; Australia; Cohort Studies; Cross-Sectional Studies; Diabetic Neuropathies; Female; Fenofibrate | 2008 |